# Myofibrillar protein accumulation but reduced protein synthesis in PDCD4-depleted myotubes

**Authors:** Stephen Mora, Lilia Alihemmat, Logan D. Davari, Termeh Ataie, Parsa Nafari Mehranjani, Luke Flewwelling, Arthur J. Cheng, Olasunkanmi A. J. Adegoke

PMC · DOI: 10.1371/journal.pone.0345305 · PLOS One · 2026-03-19

## TL;DR

Removing PDCD4 in muscle cells increases myofibrillar proteins and cell size but reduces protein synthesis and energy levels.

## Contribution

The study reveals a novel role for PDCD4 in regulating myotube size and protein accumulation through mTORC1 and AKT signaling.

## Key findings

- PDCD4 depletion increased myotube diameter and myofibrillar protein accumulation.
- Protein synthesis was suppressed despite increased phosphorylation of AKT and S6K1.
- Reduced ATP and amino acid levels suggest impaired energy metabolism in PDCD4-depleted myotubes.

## Abstract

Skeletal muscle is critical to whole-body functionality and homeostasis. The mammalian/mechanistic target of rapamycin complex 1 (mTORC1) is a nutrient/growth-factor sensitive positive regulator of skeletal muscle mass. Amongst other substrates, mTORC1 phosphorylates the ribosomal protein S6 kinase (S6K1). Activated S6K1 acts through multiple effectors, including programmed cell death 4 (PDCD4), to promote mRNA translation and protein synthesis. Much of what is known about PDCD4 is in non-muscle cells. We previously demonstrated that the effect of PDCD4 differs between myoblasts and myotubes. Here, we showed that PDCD4 depletion in myotubes enhanced myotube diameter (+36%) and accumulation of myofibrillar proteins (+163–237%). These effects occurred along with increased phosphorylation of AKTser473 (+85%) and of the mTORC1 substrate S6K1thr389 (+152%), but protein synthesis was suppressed. There was increased phosphorylation of FoxO3aser253 (+250%) and a corresponding reduction in the expression of the muscle protein ubiquitin ligase MuRF1 (–44%), but there was no significant effect on measures of proteolysis or autophagy. In starved myotubes treated with the proteasome inhibitor MG132, accumulation of ubiquitinated proteins was attenuated in PDCD4-depleted cells. PDCD4 depletion did not augment sarcoplasmic reticulum (SR) Ca2+ release capacity but was associated with reduced ATP and intracellular amino acid levels. Finally, AKT inhibition partially attenuated the effect of PDCD4 depletion on myofibrillar protein abundance. In summary, myofibrillar protein accumulation in PDCD4-depleted myotubes did not lead to improved intracellular Ca2+ handling, likely due to reduced energy level. Our data point to a pivotal role for PDCD4 in regulating myotube size.

## Linked entities

- **Genes:** PDCD4 (programmed cell death 4) [NCBI Gene 27250], RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], FOXO3 (forkhead box O3) [NCBI Gene 2309], TRIM63 (tripartite motif containing 63) [NCBI Gene 84676]
- **Proteins:** Crtc (CREB-regulated transcription coactivator), RPS6KB1 (ribosomal protein S6 kinase B1), PDCD4 (programmed cell death 4), AKT1 (AKT serine/threonine kinase 1), FOXO3 (forkhead box O3), TRIM63 (tripartite motif containing 63)
- **Chemicals:** MG132 (PubChem CID 462382)

## Full-text entities

- **Genes:** Twist1 (twist basic helix-loop-helix transcription factor 1) [NCBI Gene 22160] {aka M-Twist, Pde, Ska10, Ska<m10Jus>, Twist, bHLHa38}, Ulk1 (unc-51 like kinase 1) [NCBI Gene 22241] {aka Unc51.1, mKIAA0722}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Nup62 (nucleoporin 62) [NCBI Gene 18226] {aka D7Ertd649e, Nupc1, p62}, Pdcd4 (programmed cell death 4) [NCBI Gene 64031] {aka Dug}, Pdcd4 (programmed cell death 4) [NCBI Gene 18569] {aka D19Ucla1, Ma3, Tis}, Atg13 (autophagy related 13) [NCBI Gene 51897] {aka 1110053A20Rik, D2Ertd391e, Harbi1}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, Rps6kb1 (ribosomal protein S6 kinase B1) [NCBI Gene 83840] {aka p70 S6K-alpha}, PDCD4 (programmed cell death 4) [NCBI Gene 27250] {aka H731}, EIF4B (eukaryotic translation initiation factor 4B) [NCBI Gene 1975] {aka EIF-4B, PRO1843}, Ube2k (ubiquitin-conjugating enzyme E2K) [NCBI Gene 53323] {aka D5Ertd601e, E2-25k, HIP-2, Hip2, Hypg, Lig}, Usp8 (ubiquitin specific peptidase 8) [NCBI Gene 296121], Myh1 (myosin, heavy polypeptide 1, skeletal muscle, adult) [NCBI Gene 17879] {aka A530084A17Rik, IId, IId/x, MHC-2X/D, MHC2X/D, MYHC-IIX}, Eif4e (eukaryotic translation initiation factor 4E) [NCBI Gene 13684] {aka EG668879, Eif4e-ps, If4e, eIF-4E}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Trim63 (tripartite motif-containing 63) [NCBI Gene 433766] {aka MuRF1, RF1, Rnf28}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Map4k1 (mitogen-activated protein kinase kinase kinase kinase 1) [NCBI Gene 26411] {aka Hpk1, mHPK1}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 314856], EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, RPS6 (ribosomal protein S6) [NCBI Gene 6194] {aka S6, eS6}, Mir21a (microRNA 21a) [NCBI Gene 387140] {aka Mir21, Mirn21, mmu-mir-21, mmu-mir-21a}, p53-ps (Wistar clone pR53P1 p53 pseudogene) [NCBI Gene 301300], Ier2 (immediate early response 2) [NCBI Gene 15936] {aka Ch1, Pip92}, Scr (scruffy) [NCBI Gene 109559], Trim63 (tripartite motif containing 63) [NCBI Gene 140939] {aka Murf, Murf1, Rnf28}, Skp2 (S-phase kinase associated protein 2) [NCBI Gene 294790] {aka RGD1562456}, Foxo3 (forkhead box O3) [NCBI Gene 294515] {aka Fkhrl1, Foxo3a}, Btrc (beta-transducin repeat containing protein) [NCBI Gene 12234] {aka Beta-Trcp1, E3RS-IkappaB, E3RSIkappaB, FWD1, Fbw1a, HOS}, TRIM63 (tripartite motif containing 63) [NCBI Gene 84676] {aka CMH31, IRF, MURF1, MURF2, RNF28, SMRZ}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Fbxo32 (F-box protein 32) [NCBI Gene 171043] {aka Atrogin1, MAFbx}
- **Diseases:** inflammation (MESH:D007249), diabetes (MESH:D003920), muscle atrophy F-box (MESH:D009133), colon, breast, and lung carcinomas (MESH:D001943), cancer (MESH:D009369), obesity (MESH:D009765), metabolic diseases (MESH:D008659), loss of muscle mass (MESH:C536030)
- **Chemicals:** glucose (MESH:D005947), proline (MESH:D011392), Texas Red (MESH:C034657), puromycin (MESH:D011691), NaCl (MESH:D012965), tyrosine (MESH:D014443), NaOH (MESH:D012972), Indo-1 AM (MESH:C059587), o-phthalaldehyde (MESH:D009764), TCA (MESH:D014238), water (MESH:D014867), DTT (MESH:D004229), CaCl2 (MESH:D002122), glycine (MESH:D005998), Ponceau S (MESH:C032756), EDTA (MESH:D004492), neutral amino acids (MESH:D021542), ATP (MESH:D000255), NaHCO3 (MESH:D017693), CO2 (MESH:D002245), acetic acid (MESH:D019342), MG132 (MESH:C072553), 4',6-diamidino-2-phenylindole (MESH:C007293), MgCl2 (MESH:D015636), SDS (MESH:D012967), oligonucleotides (MESH:D009841), paraformaldehyde (MESH:C003043), HCl (MESH:D006851), 14C (MESH:C000615234), platinum (MESH:D010984), Lipofectamine (MESH:C086724), Amino acid (MESH:D000596), leucine (MESH:D007930), KCl (MESH:D011189), BCAA (MESH:D000597), methanol (MESH:D000432), Triton X-100 (MESH:D017830), O2 (MESH:D010100), valine (MESH:D014633), isoleucine (MESH:D007532), cycloheximide (MESH:D003513), 1X TBST buffer (-), K2HPO4 (MESH:C013216), phenylalanine (MESH:D010649), acetonitrile (MESH:C032159), PVDF (MESH:C024865), D-luciferin (MESH:C532924), sodium deoxycholate (MESH:D003840)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P35G, C) for 30
- **Cell lines:** L6 myoblasts — Homo sapiens (Human), Transformed cell line (CVCL_VG47), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), Opti-MEM — Mus musculus (Mouse), Hybridoma (CVCL_XY28), L6 — Mus musculus (Mouse), Hybridoma (CVCL_XK50)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001914/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001914/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001914/full.md

---
Source: https://tomesphere.com/paper/PMC13001914